Moderna COVID Vaccine Approved for Young Children in US (6 Months – 11 Years)
Moderna COVID Vaccine Now Available for Children 6 Months to 11 Years in the US
Parents and caregivers now have another tool in protecting their young children against COVID-19. The Moderna COVID-19 vaccine has been granted emergency use authorization in the United States for children aged 6 months through 11 years.
Expanded Protection for a Vulnerable Age Group
This approval marks a significant step forward in safeguarding younger children from the virus. Previously unavailable to this age group, the Moderna vaccine offers a chance for increased protection against serious illness, hospitalization, and long-term complications associated with COVID-19.
What Parents Need to Know
This decision follows rigorous review of clinical trial data demonstrating the vaccine’s safety and efficacy in young children. While side effects are generally mild and temporary, parents are encouraged to discuss any concerns with their pediatrician. The dosage for children in this age group will be smaller than the dose given to adults.